Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David W Johnson

Showing results (101-110 of 1,026) with videos related to

Pageof 103
Sort By:
BJU International|September 8, 2006
Erythropoietin administration protects against functional impairment and cell death after ischaemic renal injury in pigsColin J Forman, David W Johnson, David L Nicol
Nephrology (Carlton, Vic.)|July 20, 2007
Erythropoiesis-stimulating agent hyporesponsivenessDavid W Johnson, Carol A Pollock, Iain C Macdougall
Reviews on Recent Clinical Trials|October 27, 2015
Recent Clinical Trials of Pharmacologic Cardiovascular Interventions in Patients with Chronic Kidney Disease: An UpdateMelissa Nataatmadja, Yeoungjee Cho, Magid Fahim, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 25, 2016
Pro: Meta-analysis: the case forDavid W Mudge, Angela C Webster, David W Johnson
The New England Journal of Medicine|March 11, 2011
Frequent versus standard hemodialysisSunil V Badve, Carmel M Hawley, David W Johnson
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 29, 2009
Inhibition of nuclear factor kappa B attenuates tumour progression in an animal model of renal cell carcinomaChristudas Morais, Helen Healy, David W Johnson, et al.
Phytotherapy Research : PTR|December 5, 2009
Effect of Astragalus membranaceus and Angelica sinensis combined with Enalapril in rats with obstructive uropathyKen Wojcikowski, Hans Wohlmuth, David W Johnson, et al.
Angiogenesis|November 3, 2009
Anti-angiogenic actions of pyrrolidine dithiocarbamate, a nuclear factor kappa B inhibitorChristudas Morais, Glenda Gobe, David W Johnson, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|January 30, 2007
Modification of cardiovascular risk in hemodialysis patients: an evidence-based reviewDavid W Johnson, Ann-Maree Craven, Nicole Maree Isbel
Psychological Bulletin|February 27, 2008
Promoting early adolescents' achievement and peer relationships: the effects of cooperative, competitive, and individualistic goal structuresCary J Roseth, David W Johnson, Roger T Johnson
Pageof 103

Showing results (101-110 of 1,026) with videos related to

Sort By:
Pageof 103
BJU International|September 8, 2006
Erythropoietin administration protects against functional impairment and cell death after ischaemic renal injury in pigsColin J Forman, David W Johnson, David L Nicol
Nephrology (Carlton, Vic.)|July 20, 2007
Erythropoiesis-stimulating agent hyporesponsivenessDavid W Johnson, Carol A Pollock, Iain C Macdougall
Reviews on Recent Clinical Trials|October 27, 2015
Recent Clinical Trials of Pharmacologic Cardiovascular Interventions in Patients with Chronic Kidney Disease: An UpdateMelissa Nataatmadja, Yeoungjee Cho, Magid Fahim, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 25, 2016
Pro: Meta-analysis: the case forDavid W Mudge, Angela C Webster, David W Johnson
The New England Journal of Medicine|March 11, 2011
Frequent versus standard hemodialysisSunil V Badve, Carmel M Hawley, David W Johnson
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 29, 2009
Inhibition of nuclear factor kappa B attenuates tumour progression in an animal model of renal cell carcinomaChristudas Morais, Helen Healy, David W Johnson, et al.
Phytotherapy Research : PTR|December 5, 2009
Effect of Astragalus membranaceus and Angelica sinensis combined with Enalapril in rats with obstructive uropathyKen Wojcikowski, Hans Wohlmuth, David W Johnson, et al.
Angiogenesis|November 3, 2009
Anti-angiogenic actions of pyrrolidine dithiocarbamate, a nuclear factor kappa B inhibitorChristudas Morais, Glenda Gobe, David W Johnson, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|January 30, 2007
Modification of cardiovascular risk in hemodialysis patients: an evidence-based reviewDavid W Johnson, Ann-Maree Craven, Nicole Maree Isbel
Psychological Bulletin|February 27, 2008
Promoting early adolescents' achievement and peer relationships: the effects of cooperative, competitive, and individualistic goal structuresCary J Roseth, David W Johnson, Roger T Johnson
Pageof 103